SEC Filings - Intercept Pharmaceuticals, Inc.

Filing Date	Form	Description	View
Nov 20, 2023	15-12G	15-12G	View HTML 0001104659-23-119815.pdf 0001104659-23-119815.rtf 0001104659-23-119815.xls
Nov 14, 2023	EFFECT	EFFECT	View HTML 9999999995-23-003320.pdf 9999999995-23-003320.rtf 9999999995-23-003320.xls
Nov 14, 2023	EFFECT	EFFECT	View HTML 9999999995-23-003316.pdf 9999999995-23-003316.rtf 9999999995-23-003316.xls
Nov 14, 2023	EFFECT	EFFECT	View HTML 9999999995-23-003317.pdf 9999999995-23-003317.rtf 9999999995-23-003317.xls
Nov 13, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-117097.pdf 0001104659-23-117097.rtf 0001104659-23-117097.xls
Nov 13, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-117093.pdf 0001104659-23-117093.rtf 0001104659-23-117093.xls
Nov 13, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-117096.pdf 0001104659-23-117096.rtf 0001104659-23-117096.xls
Nov 13, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-117094.pdf 0001104659-23-117094.rtf 0001104659-23-117094.xls
Nov 13, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-117099.pdf 0001104659-23-117099.rtf 0001104659-23-117099.xls
Nov 13, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-117102.pdf 0001104659-23-117102.rtf 0001104659-23-117102.xls

Data provided by Kaleidoscope.